Cocrystal Pharma, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Cocrystal Pharma, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q2 2024.
  • Cocrystal Pharma, Inc. Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 10.2M shares, unchanged year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 10.2M 0 0% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 10.2M +2.03M +24.9% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 10.2M +2.03M +24.9% Dec 31, 2023 10-Q 2024-08-14
Q3 2023 10.2M +2.03M +24.9% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 10.2M -87.3M -89.6% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 8.14M -89.3M -91.6% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 8.14M 0 0% Dec 31, 2022 10-K 2024-03-28
Q3 2022 8.14M -89.3M -91.6% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 97.5M 0 0% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 97.5M +26M +36.4% Mar 31, 2022 10-Q 2022-05-11
Q4 2021 8.14M -62.3M -88.4% Dec 31, 2021 10-K 2023-03-29
Q3 2021 97.5M +28.9M +42.2% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 97.5M +45.3M +86.9% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 71.5M +19.3M +37.1% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 70.4M +35.3M +100% Dec 31, 2020 10-K 2022-03-23
Q3 2020 68.6M +36.9M +117% Sep 30, 2020 10-Q 2020-11-13
Q2 2020 52.1M +20.5M +64.9% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 52.1M +20.5M +64.9% Mar 31, 2020 10-Q 2020-05-13
Q4 2019 35.2M +5.21M +17.4% Dec 31, 2019 10-K 2021-03-17
Q3 2019 31.6M +1.7M +5.68% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 31.6M +1.7M +5.68% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 31.6M +7.22M +29.6% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 29.9M +5.66M +23.3% Dec 31, 2018 10-K 2020-03-27
Q3 2018 29.9M -698M -95.9% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 29.9M -697M -95.9% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 24.4M -690M -96.6% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 24.3M +474K +1.99% Dec 31, 2017 10-K 2019-04-01
Q3 2017 728M +14.2M +1.99% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 727M +22.3M +3.16% Jun 30, 2017 10-Q 2017-08-08
Q1 2017 714M +713M +101288% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 23.8M -671M -96.6% Dec 31, 2016 10-K 2018-03-21
Q3 2016 714M +19.7M +2.83% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 704M +9.88M +1.42% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 704K -687M -99.9% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 694M +694M +566782% Dec 31, 2015 10-K 2017-03-31
Q3 2015 694M +694M +566764% Sep 30, 2015 10-Q 2015-11-16
Q2 2015 694M +694M +569597% Jun 30, 2015 10-Q 2015-08-14
Q1 2015 687M +687M +565141% Mar 31, 2015 10-Q 2015-05-14
Q4 2014 122K +122K Dec 31, 2014 10-K 2016-03-15
Q3 2014 122K -70M -99.8% Sep 30, 2014 10-Q 2014-11-14
Q2 2014 122K -69.3M -99.8% Jun 30, 2014 10-Q 2014-08-14
Q1 2014 122K -63M -99.8% Mar 31, 2014 10-Q 2014-05-15
Q4 2013 0 -63.1M -100% Dec 31, 2013 10-K 2015-03-31
Q3 2013 70.1M +6.97M +11% Sep 30, 2013 10-Q 2013-11-18
Q2 2013 69.5M +7.49M +12.1% Jun 30, 2013 10-Q 2013-08-15
Q1 2013 63.1M +6.21M +10.9% Mar 31, 2013 10-Q 2013-05-10
Q4 2012 63.1M +7.96M +14.4% Dec 31, 2012 10-K 2014-03-31
Q3 2012 63.1M -4.4M -6.52% Sep 30, 2012 10-Q 2012-11-14
Q2 2012 62M -5.06M -7.54% Jun 30, 2012 10-Q/A 2012-09-28
Q1 2012 56.9M Mar 31, 2012 10-Q/A 2012-10-02
Q4 2011 55.2M +10.4M +23.3% Dec 31, 2011 10-K 2013-04-01
Q3 2011 67.5M Sep 30, 2011 10-Q 2011-11-21
Q2 2011 67M Jun 30, 2011 10-Q/A 2011-09-09
Q4 2010 44.7M Dec 31, 2010 10-K 2012-04-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.